Electronic Alerts for Acute Kidney Injury Amelioration (ELAIA-1): a completely electronic, multicentre, randomised controlled trial: design and rationale

INTRODUCTION: Acute kidney injury (AKI) is common among hospitalised patients and under-recognised by providers and yet carries a significant risk of morbidity and mortality. Electronic alerts for AKI have become more common despite a lack of strong evidence of their benefits. We designed a multicen...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutter, Marina, Martin, Melissa, Yamamoto, Yu, Biswas, Aditya, Etropolski, Boian, Feldman, Harold, Garg, Amit, Gourlie, Noah, Latham, Stephen, Lin, Haiqun, Palevsky, Paul M, Parikh, Chirag, Moreira, Erica, Ugwuowo, Ugochukwu, Wilson, Francis P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549649/
https://www.ncbi.nlm.nih.gov/pubmed/31154298
http://dx.doi.org/10.1136/bmjopen-2018-025117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549649/
https://www.ncbi.nlm.nih.gov/pubmed/31154298
http://dx.doi.org/10.1136/bmjopen-2018-025117

Ejemplares similares